These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11362791)

  • 21. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New era makes viral-load testing an important tool.
    AIDS Alert; 1996 Aug; 11(8):suppl 1-2. PubMed ID: 11363660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to antiretroviral treatment of HIV disease. Individualized therapy: the role of viral-burden measures.
    Thompson MA
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():41-50. PubMed ID: 7635916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. It's time to approve more surrogate markers.
    Scondras D
    AIDS Treat News; 1997 Mar; (No 267):3-4. PubMed ID: 11364250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling HIV-RNA viral load in vertically infected children.
    Gray L; Cortina-Borja M; Newell ML
    Stat Med; 2004 Mar; 23(5):769-81. PubMed ID: 14981674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial.
    Ghosn J; Quinson AM; Sabo N; Cotte L; Piketty C; Dorléacq N; Bravo ML; Mayers D; Harmenberg J; Mårdh G; Valdez H; Katlama C
    HIV Med; 2007 Apr; 8(3):142-7. PubMed ID: 17461857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indinavir: lightening the load.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Aug; 2(8):6-11. PubMed ID: 11363759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV RNA--should you get a quantitative HIV test today?
    Schouten JT
    STEP Perspect; 1995; 7(2):1, 17-9. PubMed ID: 11362716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral load out-performs CD4 in disease prediction.
    AIDS Alert; 1996 Apr; 11(4):42-3. PubMed ID: 11363403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.
    Steegen K; Luchters S; De Cabooter N; Reynaerts J; Mandaliya K; Plum J; Jaoko W; Verhofstede C; Temmerman M
    J Virol Methods; 2007 Dec; 146(1-2):178-87. PubMed ID: 17686534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 load quantitation: a 17-year perspective.
    Holodniy M
    J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the principles of anti-HIV drug therapy.
    Horn T
    Surviv News (Atlanta Ga); 2001 Jul; ():13. PubMed ID: 11683014
    [No Abstract]   [Full Text] [Related]  

  • 38. Discordant immunological and virological responses to antiretroviral therapy.
    Schechter M; Tuboi SH
    J Antimicrob Chemother; 2006 Sep; 58(3):506-10. PubMed ID: 16854959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HAART does not stop all HIV replication.
    Res Initiat Treat Action; 1999 Dec; 5(5):23-4. PubMed ID: 11366891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.